Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial

31 Aug 2017

Abstract excerpt

STUDY QUESTION: Does administration of corifollitropin alfa followed by highly purified (hp) HMG result in higher ongoing pregnancy rates compared with daily recombinant FSH (rFSH) in young poor responders? SUMMARY ANSWER: Corifollitropin alfa followed by hp-HMG does not increase ongoing pregnancy rates compared with rFSH in young poor responders, although more supernumerary cryopreserved embryos were obtained...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hypothalamic control of reproductive hormones
Share to Ovarian function and disorders
Share to Reproductive Biology and Fertility

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29040589
DOI: 10.1093/humrep/dex296

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trialPMID 29040589Read ↗

Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders undergoing intracytoplasmic sperm injectionSemantic proximity Read ↗

Long-acting FSH versus daily FSH for women undergoing assisted reproductionSemantic proximity Read ↗

Young age does not protect against the adverse effects of reduced ovarian reserve—an eight year studySemantic proximity Read ↗

An extremely patient-friendly and efficient stimulation protocol for assisted reproductive technology in normal and high respondersSemantic proximity Read ↗

The Bologna criteria for poor ovarian response: a contemporary critical appraisal.Semantic proximity Read ↗

Growth Hormone Enhances Ovarian Response but not Live Births in DOR Patients Undergoing PPOS with Freeze-all Strategy: A Retrospective Cohort Study Contrasted with Kuntai CapsuleSemantic proximity Read ↗

Predicting ongoing pregnancy following ovulation induction with recombinant FSH in women with polycystic ovary syndromeSemantic proximity Read ↗

Age-related decline in the expression of GDF9 and BMP15 genes in follicle fluid and granulosa cells derived from poor ovarian responders Semantic proximity Read ↗

Influence of ovarian stimulation with HP-hMG or recombinant FSH on embryo quality parameters in patients undergoing IVFSemantic proximity Read ↗

A rational approach to the management of low responders in in-vitro fertilization: OpinionSemantic proximity Read ↗

Luteal phase anovulatory follicles result in the production of competent oocytes: intra-patient paired case-control study comparing follicular versus luteal phase stimulations in the same ovarian cycleSemantic proximity Read ↗

Double Stimulation in the Same Ovarian Cycle (DuoStim) to Maximize the Number of Oocytes Retrieved From Poor Prognosis Patients: A Multicenter Experience and SWOT AnalysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.